Evidence map›Paper›PMID 33679693›Full record

ArticleFrontiers in immunology2020

Dissection of the Pre-Germinal Center B-Cell Maturation Pathway in Common Variable Immunodeficiency Based on Standardized Flow Cytometric EuroFlow Tools.

Lucía Del Pino-Molina, Eduardo López-Granados, Quentin Lecrevisse, Juan Torres Canizales, Martín Pérez-Andrés, Elena Blanco, Marjolein Wentink, Carolien Bonroy, Jana Nechvatalova, Tomas Milota and 7 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Elevated CD21Journal of clinical immunology · 2022
    Trial
  2. Article
  3. Effects of two different variants in theFrontiers in immunology · 2025
    Article
  4. Article
  5. Detection of specific RBDFrontiers in immunology · 2023
    Article
  6. NF-kB's contribution to B cell fate decisions.Frontiers in immunology · 2023
    Review
  7. Article
  8. B cells in human lymphoid structures.Clinical and experimental immunology · 2022
    Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 12 institutions in 6 countries.

Lucía Del Pino-MolinaClinical Immunology Department, La Paz University Hospital and Lymphocyte Pathophysiology in Immunodeficiencies Group, La Paz Institute for Health Research (IdiPAZ) and Center for Biomedical Network Research on Rare Diseases (CIBERER U767), Madrid, Spain.
Eduardo López-GranadosClinical Immunology Department, La Paz University Hospital and Lymphocyte Pathophysiology in Immunodeficiencies Group, La Paz Institute for Health Research (IdiPAZ) and Center for Biomedical Network Research on Rare Diseases (CIBERER U767), Madrid, Spain.
Quentin LecrevisseClinical and Translation Research Program, Cancer Research Centre (IBMCC, USAL-CSIC), Department of Medicine, Cytometry Service (NUCLEUS), University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Juan Torres CanizalesClinical Immunology Department, La Paz University Hospital and Lymphocyte Pathophysiology in Immunodeficiencies Group, La Paz Institute for Health Research (IdiPAZ) and Center for Biomedical Network Research on Rare Diseases (CIBERER U767), Madrid, Spain.
Martín Pérez-AndrésClinical and Translation Research Program, Cancer Research Centre (IBMCC, USAL-CSIC), Department of Medicine, Cytometry Service (NUCLEUS), University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Elena BlancoClinical and Translation Research Program, Cancer Research Centre (IBMCC, USAL-CSIC), Department of Medicine, Cytometry Service (NUCLEUS), University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Marjolein WentinkDepartment of Immunology, Erasmus University Medical Center (Erasmus MC), Rotterdam, Netherlands.
Carolien BonroyDepartment of Laboratory Medicine, University Hospital Ghent, Ghent, Belgium.
Jana NechvatalovaDepartment of Allergology and Clinical Immunology, Faculty of Medicine, Masaryk University and St Anne's University Hospital in Brno, Brno, Czechia.
Tomas MilotaDepartment of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia.
Anne-Kathrin KienzlerNuffield Department of Medicine, Experimental Medicine Division, University of Oxford, Oxford, United Kingdom.
Jan PhilippéDepartment of Laboratory Medicine, University Hospital Ghent, Ghent, Belgium.
Ana E SousaInstituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Mirjam van der BurgDepartment of Pediatrics, Laboratory for Immunology, Leiden University Medical Center, Leiden, Netherlands.
Tomas KalinaCLIP - Childhood Leukemia Investigation Prague, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czechia.
Jacques J M van DongenDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center (LUMC), Leiden, Netherlands.
Alberto OrfaoClinical and Translation Research Program, Cancer Research Centre (IBMCC, USAL-CSIC), Department of Medicine, Cytometry Service (NUCLEUS), University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Centro de Investigación del Cáncer · ESCentre for Biomedical Network Research on Rare Diseases · ESGhent University Hospital · BELeiden University Medical Center · NLCharles University · CZErasmus MC · NLHospital La Paz Institute for Health Research · ESInstituto de Investigación Biomédica de Salamanca · ESSt. Anne's University Hospital Brno · CZUniversity Hospital in Motol · CZUniversity of Lisbon · PTUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Common Variable Immunodeficiency (CVID) is characterized by defective antibody production and hypogammaglobulinemia. Flow cytometry immunophenotyping of blood lymphocytes has become of great relevance for the diagnosis and classification of CVID, due to an impaired differentiation of mature post-germinal-center (GC) class-switched memory B-cells (MBC) and severely decreased plasmablast/plasma cell (Pb) counts. Here, we investigated in detail the pre-GC B-cell maturation compartment in blood of CVID patients. Methods: In this collaborative multicentric study the EuroFlow PID 8-color Results: The Conclusion: Our results show that maturation of pre-GC B-cells in blood of CVID is systematically altered with up to four distinctly altered maturation profiles. Further studies, are necessary to better understand the impact of such alterations on the post-GC defects and the clinical heterogeneity of CVID.

Indexed as

Flow CytometryImmunophenotypingAdolescentAdultAgedAged, 80 and overAntigens, CDCase-Control StudiesCommon Variable ImmunodeficiencyEuropeFemaleHumansMaleMiddle AgedPhenotypePrecursor Cells, B-LymphoidAntigens, CDCVIDEuroFlow standardizationexpression markersPre-GC B-cell tubepre-GC maturation pathway

Identifiers

PMID33679693
PMCPMC7925888
OpenAlexW3133309248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.